SCHEMBL21055025

SCHEMBL21055025

CCCCCCCCC[CH]N1CCC1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
FAAH O00519 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
EP300 Q09472 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716649 0.95 TSHR (0.46) TSHRFAAHTRPV1
SCHEMBL6715588 0.93 TSHR (0.44) TSHRFAAHTRPV1
SCHEMBL6722997 0.93 TSHR (0.42) TSHRFAAHTRPV1
SCHEMBL6714009 0.91 L3MBTL1 (0.44) TSHRFAAHTRPV1
SCHEMBL21925314 0.91 TSHR (0.44) TSHRFAAHTRPV1
SCHEMBL4630231 0.86 TSHR (0.42) TSHRTRPV1
SCHEMBL2094342 0.84 L3MBTL1 (0.41) TSHR
SCHEMBL8207554 0.78 GNAO1 (0.43) TSHR
SCHEMBL378009 0.75
SCHEMBL9325532 0.72 FAAH (0.47) TSHRFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720494-A2 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. (US) 2020-10-14 EP disclosed
WO-2019113375-A2 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. (US) 2019-06-13 WO disclosed